|
Efforts to correct perceived
weaknesses in the current generation of coated devices has led to an
intense level of activity, with more than two dozen
technology-driven companies pursuing development-stage stents
designed to provide improved patient outcomes by eliminating or at
least mitigating the problems of marketed devices. These
participants are exploring a number of new and innovative approaches
that include novel stent geometries, non-durable stents, new classes
of drugs, and novel coating application technologies and strategies.
Publication Date:
May 2008 |
